Sunday, February 9, 2025

Bioliberty’s Robotic Glove Receives Funding Boost to Aid Stroke Rehabilitation

Similar articles

Edinburgh-based medtech start-up Bioliberty has secured £435,000 in funding for stroke rehabilitation from Innovate UK’s Biomedical Catalyst, a grant funding mechanism aiming at transforming innovative ideas into successful businesses. Bioliberty’s breakthrough technology is a soft robotic glove designed to assist stroke patients in rehabilitating their hand movements, a task often hindered after a stroke. Collaboration with healthcare professionals resulted in development. Glove incorporates sensors adjust resistance levels, and tailoring rehabilitation exercises for each user. The new funding will further enhance the machine learning and data collection aspects of the product.

Table of Contents

Subscribe Weekly Market Access News

* indicates required

Addressing the Urgent Need for Stroke Rehabilitation Innovation in the UK

Stroke is a prevalent health issue, with statistics from the UK’s Stroke Association indicating that someone in the country experiences a stroke every five minutes, affecting approximately 100,000 individuals annually. An estimated 1.3 million people in the UK have suffered from a stroke, many requiring ongoing therapy to recover from its effects. Recent guidelines from the National Institute for Health and Care Excellence (NICE) recommend stroke victims receive up to three hours of daily rehabilitation, five days a week. However, concerns have been raised about the NHS’s capacity to meet these targets.

Bioliberty, which has already garnered over £3.5 million in funding from private and public sources and created eight skilled roles within the company in the last six months, believes its innovative technology can help address these challenges. The company envisions its soft robotic glove revolutionizing rehabilitation technology, with upcoming trials set to impact in the United States and a growing demand for innovative rehabilitation solutions in the UK, aligned with the latest NICE guidelines.

Conan Bradley, co-founder at Bioliberty, emphasized the company’s commitment to advancing rehabilitation technology and its potential for positive impacts on stroke patients’ care. He also highlighted the role of the National Robotarium’s advanced facilities and ecosystem in their product development.

Stroke Rehabilitation

Global Implications of Bioliberty’s Robotic Solution

Lisa Farrell, business development manager at the National Robotarium, emphasized the importance of addressing the global need for robotic solutions in stroke rehabilitation. Stroke remains a leading cause of disability worldwide, making Bioliberty’s product a valuable addition to healthcare technology.

UK government minister for Scotland Malcolm Offord praised Bioliberty’s pioneering technology, highlighting its potential to enhance stroke patients’ care during rehabilitation. He underscored the UK Government’s investment in the National Robotarium as part of its commitment to fostering research, supporting high-quality jobs, and promoting growth in the healthcare sector.

 

Resource: Medtechnews, December 05, 2023

You can follow our news on our Telegram, LinkedIn and Youtube accounts.


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article